The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Sorenson Development, startups are often financed by Wharton Capital, University Venture Fund, National Institutes of Health. The meaningful sponsors for the fund in investment in the same round are WT Investment Advisors Fund, Wharton Capital, Unilever Ventures. In the next rounds fund is usually obtained by WT Investment Advisors Fund, Unilever Ventures, TPG-Axon Capital.
We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Merrimack Pharmaceuticals.
The important activity for fund was in 2006. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2012.
Related Funds
Fund Name | Location |
AlphaCoin Fund | Boston, Massachusetts, United States |
Bitrise Capital | Central, Central Region, Singapore |
Ceniarth | California, San Francisco, United States |
Chengdu Mengting Electronic Commerce | Chengdu, China, Sichuan |
CoFound Partners | New York, New York, United States |
Cognitive Investment | Seoul, Seoul-t'ukpyolsi, South Korea |
Connecticut Center for Advanced Technology | Connecticut, East Hartford, United States |
Dongzhao Shanghai Group | - |
HgCapital Trust plc | England, London, United Kingdom |
MedImmune | Louisiana, Maryland, United States |
Miven Venture Partners | California, Menlo Park, United States |
Mount Sinai Health System | New York, New York, United States |
Nueva Ventures | California, San Mateo, United States |
Shanxi Keji Chuangye Touzi | China, Shaanxi, Xian Shi |
Shoko Chukin Bank | New York, New York, United States |
Trihill Capital | - |
Xizang Tongmei Wenhua | Chengguan District, China, Lhasa |
Yongda Zichan | China, Hongkou District |
Zicom Holdings | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Merrimack Pharmaceuticals | $28M | 05 May 2004 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Merrimack Pharmaceuticals | $28M | 05 May 2004 | Cambridge, Massachusetts, United States |